{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:46:52Z","timestamp":1789739212635,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R35CA197465"],"award-info":[{"award-number":["R35CA197465"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Acute myeloid leukemia (AML) remains incurable, largely due to its resistance to conventional treatments. Here, we find that increased abundance of the ubiquitin ligase RNF5 contributes to AML development and survival. High RNF5 expression in AML patient specimens correlates with poor prognosis. RNF5 inhibition decreases AML cell growth in culture, in patient-derived xenograft (PDX) samples and in vivo, and delays development of MLL-AF9\u2013driven leukemogenesis in mice, prolonging their survival. RNF5 inhibition causes transcriptional changes that overlap with those seen upon histone deacetylase (HDAC)1 inhibition. RNF5 induces the formation of K29 ubiquitin chains on the histone-binding protein RBBP4, promoting its recruitment to and subsequent epigenetic regulation of genes involved in AML maintenance. Correspondingly, RNF5 or RBBP4 knockdown enhances AML cell sensitivity to HDAC inhibitors. Notably, low expression of both\n                    <jats:italic>RNF5<\/jats:italic>\n                    and\n                    <jats:italic>HDAC<\/jats:italic>\n                    coincides with a favorable prognosis. Our studies identify an ERAD-independent role for RNF5, demonstrating that its control of RBBP4 constitutes an epigenetic pathway that drives AML, and highlight RNF5\/RBBP4 as markers useful to stratify patients for treatment with HDAC inhibitors.\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-25664-7","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T06:04:04Z","timestamp":1631513044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors"],"prefix":"10.1038","volume":"12","author":[{"given":"Ali","family":"Khateb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anagha","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8718-9453","authenticated-orcid":false,"given":"Darren","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8564-0848","authenticated-orcid":false,"given":"Joo Sang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikrame","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8916-7303","authenticated-orcid":false,"given":"Yu","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2124-2706","authenticated-orcid":false,"given":"Tongwu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Livneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1773-7677","authenticated-orcid":false,"given":"Irmela","family":"Jeremias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Burian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Almog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurit","family":"Horesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishai","family":"Ofran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8558-6711","authenticated-orcid":false,"given":"Kevin","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5657-0681","authenticated-orcid":false,"given":"Kristiina","family":"Vuori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eytan","family":"Ruppin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5240-9356","authenticated-orcid":false,"given":"Aniruddha J.","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3859-0400","authenticated-orcid":false,"given":"Ze\u2019ev A.","family":"Ronai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"key":"25664_CR1","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"Cancer Genome Atlas Research, N.","year":"2013","unstructured":"Cancer Genome Atlas Research, N. et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med 368, 2059\u20132074 (2013).","journal-title":"N. Engl. J. Med"},{"key":"25664_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0268-960X(03)00040-7","volume":"18","author":"K Mrozek","year":"2004","unstructured":"Mrozek, K., Heerema, N. A. & Bloomfield, C. D. Cytogenetics in acute leukemia. Blood Rev. 18, 115\u2013136 (2004).","journal-title":"Blood Rev."},{"key":"25664_CR3","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1182\/blood-2011-03-343988","volume":"118","author":"Y Shen","year":"2011","unstructured":"Shen, Y. et al. Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia. Blood 118, 5593\u20135603 (2011).","journal-title":"Blood"},{"key":"25664_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H Dohner","year":"2010","unstructured":"Dohner, H. et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115, 453\u2013474 (2010).","journal-title":"Blood"},{"key":"25664_CR5","doi-asserted-by":"publisher","first-page":"12099","DOI":"10.1074\/jbc.M808222200","volume":"284","author":"M Tcherpakov","year":"2009","unstructured":"Tcherpakov, M. et al. Regulation of endoplasmic reticulum-associated degradation by RNF5-dependent ubiquitination of JNK-associated membrane protein (JAMP). J. Biol. Chem. 284, 12099\u201312109 (2009).","journal-title":"J. Biol. Chem."},{"key":"25664_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.cell.2006.06.041","volume":"126","author":"JM Younger","year":"2006","unstructured":"Younger, J. M. et al. Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell 126, 571\u2013582 (2006).","journal-title":"Cell"},{"key":"25664_CR7","doi-asserted-by":"publisher","first-page":"8172","DOI":"10.1158\/0008-5472.CAN-07-0045","volume":"67","author":"KD Bromberg","year":"2007","unstructured":"Bromberg, K. D. et al. Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancer. Cancer Res 67, 8172\u20138179 (2007).","journal-title":"Cancer Res"},{"key":"25664_CR8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ccell.2015.02.006","volume":"27","author":"YJ Jeon","year":"2015","unstructured":"Jeon, Y. J. et al. Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies. Cancer Cell 27, 354\u2013369 (2015).","journal-title":"Cancer Cell"},{"key":"25664_CR9","doi-asserted-by":"publisher","first-page":"e1003007","DOI":"10.1371\/journal.pgen.1003007","volume":"8","author":"E Kuang","year":"2012","unstructured":"Kuang, E. et al. Regulation of ATG4B stability by RNF5 limits basal levels of autophagy and influences susceptibility to bacterial infection. PLoS Genet 8, e1003007 (2012).","journal-title":"PLoS Genet"},{"key":"25664_CR10","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1016\/j.celrep.2018.08.057","volume":"24","author":"Y Fujita","year":"2018","unstructured":"Fujita, Y. et al. Regulation of S100A8 stability by RNF5 in intestinal epithelial cells determines intestinal inflammation and severity of colitis. Cell Rep. 24, 3296\u20133311 e3296 (2018).","journal-title":"Cell Rep."},{"key":"25664_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1182\/blood-2007-10-115873","volume":"112","author":"G Garcia-Manero","year":"2008","unstructured":"Garcia-Manero, G. et al. Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia. Blood 112, 981\u2013989 (2008).","journal-title":"Blood"},{"key":"25664_CR12","doi-asserted-by":"crossref","unstructured":"Masetti, R., Serravalle, S., Biagi, C. & Pession, A. The role of HDACs inhibitors in childhood and adolescence acute leukemias. J. Biomed. Biotechnol. 2011, 148046 (2011).","DOI":"10.1155\/2011\/148046"},{"key":"25664_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1182\/blood.V94.2.417","volume":"94","author":"RL Redner","year":"1999","unstructured":"Redner, R. L., Wang, J. & Liu, J. M. Chromatin remodeling and leukemia: new therapeutic paradigms. Blood 94, 417\u2013428 (1999).","journal-title":"Blood"},{"key":"25664_CR14","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1200\/JCO.2005.16.600","volume":"23","author":"KN Bhalla","year":"2005","unstructured":"Bhalla, K. N. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies. J. Clin. Oncol. 23, 3971\u20133993 (2005).","journal-title":"J. Clin. Oncol."},{"key":"25664_CR15","doi-asserted-by":"publisher","first-page":"e13941","DOI":"10.7554\/eLife.13941","volume":"5","author":"CJ Millard","year":"2016","unstructured":"Millard, C. J. et al. The structure of the core NuRD repression complex provides insights into its interaction with chromatin. Elife 5, e13941 (2016).","journal-title":"Elife"},{"key":"25664_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0092-8674(00)80216-0","volume":"89","author":"Y Zhang","year":"1997","unstructured":"Zhang, Y., Iratni, R., Erdjument-Bromage, H., Tempst, P. & Reinberg, D. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 89, 357\u2013364 (1997).","journal-title":"Cell"},{"key":"25664_CR17","first-page":"563","volume":"13","author":"Q Guo","year":"2020","unstructured":"Guo, Q. et al. Expression of HDAC1 and RBBP4 correlate with clinicopathologic characteristics and prognosis in breast cancer. Int J. Clin. Exp. Pathol. 13, 563\u2013572 (2020).","journal-title":"Int J. Clin. Exp. Pathol."},{"key":"25664_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.hbpd.2019.08.006","volume":"18","author":"YD Li","year":"2019","unstructured":"Li, Y. D., Lv, Z., Xie, H. Y. & Zheng, S. S. Retinoblastoma binding protein 4 up-regulation is correlated with hepatic metastasis and poor prognosis in colon cancer patients. Hepatobiliary Pancreat. Dis. Int 18, 446\u2013451 (2019).","journal-title":"Hepatobiliary Pancreat. Dis. Int"},{"key":"25664_CR19","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.celrep.2016.02.045","volume":"14","author":"GJ Kitange","year":"2016","unstructured":"Kitange, G. J. et al. Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins. Cell Rep. 14, 2587\u20132598 (2016).","journal-title":"Cell Rep."},{"key":"25664_CR20","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1080\/10428194.2018.1509314","volume":"60","author":"BC Heckl","year":"2019","unstructured":"Heckl, B. C. et al. Frequent and reliable engraftment of certain adult primary acute lymphoblastic leukemias in mice. Leuk. Lymphoma Mar. 60, 848\u2013851 (2019).","journal-title":"Leuk. Lymphoma Mar."},{"key":"25664_CR21","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1038\/sj.onc.1207108","volume":"22","author":"DG Breckenridge","year":"2003","unstructured":"Breckenridge, D. G., Germain, M., Mathai, J. P., Nguyen, M. & Shore, G. C. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 22, 8608\u20138618 (2003).","journal-title":"Oncogene"},{"key":"25664_CR22","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature04980","volume":"442","author":"AV Krivtsov","year":"2006","unstructured":"Krivtsov, A. V. et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442, 818\u2013822 (2006).","journal-title":"Nature"},{"key":"25664_CR23","doi-asserted-by":"publisher","first-page":"e1609","DOI":"10.1371\/journal.pone.0001609","volume":"3","author":"A Delaunay","year":"2008","unstructured":"Delaunay, A. et al. The ER-bound RING finger protein 5 (RNF5\/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositis. PLoS One 3, e1609 (2008).","journal-title":"PLoS One"},{"key":"25664_CR24","doi-asserted-by":"publisher","first-page":"89643","DOI":"10.18632\/oncotarget.20288","volume":"8","author":"L Pan","year":"2017","unstructured":"Pan, L. et al. DHX15 is associated with poor prognosis in acute myeloid leukemia (AML) and regulates cell apoptosis via the NF-kB signaling pathway. Oncotarget 8, 89643\u201389654 (2017).","journal-title":"Oncotarget"},{"key":"25664_CR25","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/sj.cdd.4402139","volume":"14","author":"Y Tabe","year":"2007","unstructured":"Tabe, Y. et al. Novel role of HDAC inhibitors in AML1\/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1. Cell Death Differ. 14, 1443\u20131456 (2007).","journal-title":"Cell Death Differ."},{"key":"25664_CR26","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.12659\/MSM.911904","volume":"25","author":"M Watek","year":"2019","unstructured":"Watek, M. et al. Hypogelsolinemia in patients diagnosed with acute myeloid leukemia at initial stage of sepsis. Med Sci. Monit. 25, 1452\u20131458 (2019).","journal-title":"Med Sci. Monit."},{"key":"25664_CR27","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1101\/gad.1035902","volume":"16","author":"A Kuzmichev","year":"2002","unstructured":"Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P. & Reinberg, D. Histone methyltransferase activity associated with a human multiprotein complex containing the enhancer of Zeste protein. Genes Dev. 16, 2893\u20132905 (2002).","journal-title":"Genes Dev."},{"key":"25664_CR28","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1007\/s00018-012-1256-2","volume":"70","author":"HF Allen","year":"2013","unstructured":"Allen, H. F., Wade, P. A. & Kutateladze, T. G. The NuRD architecture. Cell Mol. Life Sci. 70, 3513\u20133524 (2013).","journal-title":"Cell Mol. Life Sci."},{"key":"25664_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0165-4608(03)00102-X","volume":"146","author":"S Casas","year":"2003","unstructured":"Casas, S. et al. Changes in apoptosis-related pathways in acute myelocytic leukemia. Cancer Genet. Cytogenet 146, 89\u2013101 (2003).","journal-title":"Cancer Genet. Cytogenet"},{"key":"25664_CR30","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1091\/mbc.e07-06-0601","volume":"19","author":"D Morito","year":"2008","unstructured":"Morito, D. et al. Gp78 cooperates with RMA1 in endoplasmic reticulum-associated degradation of CFTRDeltaF508. Mol. Biol. Cell 19, 1328\u20131336 (2008).","journal-title":"Mol. Biol. Cell"},{"key":"25664_CR31","doi-asserted-by":"publisher","first-page":"19266","DOI":"10.1073\/pnas.1008937107","volume":"107","author":"C Xu","year":"2010","unstructured":"Xu, C. et al. Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2). Proc. Natl Acad. Sci. USA 107, 19266\u201319271 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25664_CR32","doi-asserted-by":"publisher","first-page":"6630","DOI":"10.1074\/jbc.M114.610196","volume":"290","author":"Z Liu","year":"2015","unstructured":"Liu, Z. et al. Structural basis of plant homeodomain finger 6 (PHF6) recognition by the retinoblastoma binding protein 4 (RBBP4) component of the nucleosome remodeling and deacetylase (NuRD) complex. J. Biol. Chem. 290, 6630\u20136638 (2015).","journal-title":"J. Biol. Chem."},{"key":"25664_CR33","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1038\/onc.2011.32","volume":"30","author":"J Duque-Afonso","year":"2011","unstructured":"Duque-Afonso, J. et al. The HDAC class I-specific inhibitor entinostat (MS-275) effectively relieves epigenetic silencing of the LAT2 gene mediated by AML1\/ETO. Oncogene 30, 3062\u20133072 (2011).","journal-title":"Oncogene"},{"key":"25664_CR34","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.18632\/oncotarget.26877","volume":"10","author":"K Clarke","year":"2019","unstructured":"Clarke, K. et al. The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered histone H3K9 marks in myeloid leukaemia cells. Oncotarget 10, 3462\u20133471 (2019).","journal-title":"Oncotarget"},{"key":"25664_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ctrv.2017.10.007","volume":"61","author":"L Argnani","year":"2017","unstructured":"Argnani, L., Broccoli, A. & Zinzani, P. L. Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease. Cancer Treat. Rev. 61, 61\u201369 (2017).","journal-title":"Cancer Treat. Rev."},{"key":"25664_CR36","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1182\/blood-2004-05-1693","volume":"105","author":"JC Byrd","year":"2005","unstructured":"Byrd, J. C. et al. A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia. Blood 105, 959\u2013967 (2005).","journal-title":"Blood"},{"key":"25664_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04647-1","volume":"9","author":"JS Lee","year":"2018","unstructured":"Lee, J. S. et al. Harnessing synthetic lethality to predict the response to cancer treatment. Nat. Commun. 9, 2546 (2018).","journal-title":"Nat. Commun."},{"key":"25664_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09525-y","volume":"10","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5(\u2212\/\u2212) mice. Nat. Commun. 10, 1492 (2019).","journal-title":"Nat. Commun."},{"key":"25664_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physrev.00012.2016","volume":"97","author":"N Foot","year":"2017","unstructured":"Foot, N., Henshall, T. & Kumar, S. Ubiquitination and the regulation of membrane proteins. Physiol. Rev. 97, 253\u2013281 (2017).","journal-title":"Physiol. Rev."},{"key":"25664_CR40","doi-asserted-by":"publisher","first-page":"W325","DOI":"10.1093\/nar\/gku383","volume":"42","author":"Q Zhao","year":"2014","unstructured":"Zhao, Q. et al. GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs. Nucleic Acids Res 42, W325\u2013W330 (2014).","journal-title":"Nucleic Acids Res"},{"key":"25664_CR41","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nmeth.2847","volume":"11","author":"C Pabst","year":"2014","unstructured":"Pabst, C. et al. Identification of small molecules that support human leukemia stem cell activity ex vivo. Nat. Methods 11, 436\u2013442 (2014).","journal-title":"Nat. Methods"},{"key":"25664_CR42","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nmeth.2557","volume":"10","author":"D Mellacheruvu","year":"2013","unstructured":"Mellacheruvu, D. et al. The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nat. Methods 10, 730\u2013736 (2013).","journal-title":"Nat. Methods"},{"key":"25664_CR43","doi-asserted-by":"publisher","first-page":"E4639","DOI":"10.1073\/pnas.1608644113","volume":"113","author":"O Braten","year":"2016","unstructured":"Braten, O. et al. Numerous proteins with unique characteristics are degraded by the 26S proteasome following monoubiquitination. Proc. Natl Acad. Sci. USA 113, E4639\u2013E4647 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25664_CR44","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372 (2008).","journal-title":"Nat. Biotechnol."},{"key":"25664_CR45","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498\u20132504 (2003).","journal-title":"Genome Res"},{"key":"25664_CR46","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.celrep.2016.09.079","volume":"17","author":"K Tzelepis","year":"2016","unstructured":"Tzelepis, K. et al. A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia. Cell Rep. 17, 1193\u20131205 (2016).","journal-title":"Cell Rep."},{"key":"25664_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"25664_CR48","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"25664_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).","journal-title":"Genome Biol."},{"key":"25664_CR50","doi-asserted-by":"publisher","first-page":"e0157022","DOI":"10.1371\/journal.pone.0157022","volume":"11","author":"H Varet","year":"2016","unstructured":"Varet, H., Brillet-Gueguen, L., Coppee, J. Y. & Dillies, M. A. SARTools: a DESeq2- and EdgeR-based R pipeline for comprehensive differential analysis of RNA-Seq data. PLoS One 11, e0157022 (2016).","journal-title":"PLoS One"},{"key":"25664_CR51","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian, A. et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell 171, 1437\u20131452 e1417 (2017).","journal-title":"Cell"}],"updated-by":[{"DOI":"10.1038\/s41467-026-73691-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25664-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:05:48Z","timestamp":1781186748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25664-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["25664"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-25664-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.25.349241","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]},"assertion":[{"value":"23 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-026-73691-z","URL":"https:\/\/doi.org\/10.1038\/s41467-026-73691-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ZAR is co-founder and serves as scientific advisor to Pangea Therapeutics. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5397"}}